After years of 'bootstrapping,' this independent cannabis dispensary decided to sell
Peninsula Alternative Health is being sold, but its brand will continue and its CEO is staying on. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 28, 2022 Category: Pharmaceuticals Authors: Giacomo Bologna Source Type: news

Johnson & Johnson to Participate in Citi ’s 2022 Virtual Healthcare Conference
New Brunswick, NJ (January 27th, 2022) - Johnson & Johnson (NYSE: JNJ) will participate in Citi’s 2022 Virtual Healthcare Conference on Wednesday, February 23rd, Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time). This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com. A webcast and podcast replay will be available approximately 48 hours after the live webcast. (Source: Johnson and Johnson)
Source: Johnson and Johnson - January 27, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

With New Book, Parsley Health Founder Dr. Robin Berzin Wants To Bring Holistic Health To All
Six years after launching Parsley Health, Dr. Robin Berzin has built the service into the nation's leading holistic medicine provider, raising $100 million along the way. Now, the founder is bringing the company's ethos and approach to mental health to even more people with a new book. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 27, 2022 Category: Pharmaceuticals Authors: Gabby Shacknai, Contributor Tags: ForbesWomen /forbeswomen Leadership /leadership Innovation /innovation Healthcare /healthcare Source Type: news

Recommendations Simplified for Pneumococcal Vaccination
THURSDAY, Jan. 27, 2022 -- A new policy has simplified the Advisory Committee on Immunization Practices (ACIP) pneumococcal vaccination recommendations; the updated recommendations are published in the Jan. 28 issue of the U.S. Centers for Disease... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

Third mRNA Vaccine Dose Ups Effectiveness Against Hospitalization
THURSDAY, Jan. 27, 2022 -- Receipt of a third COVID-19 mRNA vaccine dose is associated with increased vaccine effectiveness against COVID-19 hospitalization, according to research published in the Jan. 28 issue of the U.S. Centers for Disease... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

Moderna Begins Testing Booster Shot Aimed at Omicron
THURSDAY, Jan. 27, 2022 -- Moderna Inc. announced Wednesday that it has launched a trial that will study the power of a redesigned booster shot -- one that homes in on the highly contagious omicron variant. In announcing its trial, Moderna also... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

Scientists Watch, Worry About New'Stealth' Version of Omicron Variant
THURSDAY, Jan. 27, 2022 -- A " stealthier " version of the omicron variant that has been spotted in the United States and dozens of other countries is being closely monitored by health officials and scientists. The variant, called BA.2, has genetic... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

Obamacare Provider Oscar Health Says Revenue To Top $6 Billion On Record Enrollment
Oscar Health said its 2022 enrollment will top one million members and the company will reap more than $6.1 billion in premium revenue but last year losses will exceed a half billion dollars. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 27, 2022 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Enterprise Tech /enterprise-tech Editors' Pick editors-pick business pharma Source Type: news

Hospital Defends Decision to Deny Heart Transplant to Unvaccinated Man
THURSDAY, Jan. 27, 2022 -- In response to claims that a man was denied a heart transplant because he refused to get vaccinated against COVID-19, Brigham and Women's Hospital in Boston said Wednesday that its transplant policies mirror those used... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

Populist Countries —Like The U.S.—Had More Excess Covid Deaths In 2020, Study Finds
The average rate of excess mortalities was doubled in countries ruled by populist governments. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 27, 2022 Category: Pharmaceuticals Authors: Carlie Porterfield, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus consumer Source Type: news

Fables And Misperceptions About Drug Makers And Drug Pricing Are Misleading Customers About The Value The Industry Provides
Once it is understood how new drugs are developed it becomes easier to understand why new drugs are priced the way they are. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 27, 2022 Category: Pharmaceuticals Authors: Rita Numerof, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Obamacare Enrollment Hits Record 14.5 Million, Including 5.8 Million Newly Insured
A record 14.5 million Americans have purchased individual coverage under the Affordable Care Act known as Obamacare for this year. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 27, 2022 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Enterprise Tech /enterprise-tech Decision Maker Content decisionmaker business pharma Source Type: news

Patients need to pay less for their medicines. States can help.
No one should struggle to afford the medicines they need. Unfortunately, some patients continue to bear more of their medicine costs at the pharmacy counter. Patients with deductibles have seen their out-of-pocket costs for brand medicines in some areas increase50% since 2015. (Source: The Catalyst)
Source: The Catalyst - January 27, 2022 Category: Pharmaceuticals Authors: Scott LaGanga Tags: Health Insurance Out-of-Pocket Costs Proactive Agenda Source Type: news

Functions Of SARS-CoV-2 NSP12 Polymerase: Replication, Transcription, And Suppression Of Natural Immunity
In February 2021, a paper published in Cellular& Molecular Immunology confirmed that NSP12 suppresses the activity of a coding gene, IRF3 (interferon regulatory factor 3), key to the production of interferon. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 27, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

USPSTF: Evidence Still Lacking for Atrial Fibrillation Screening
THURSDAY, Jan. 27, 2022 -- The U.S. Preventive Services Task Force (USPSTF) concludes that current evidence remains insufficient for weighing the benefits and harms of screening for atrial fibrillation (AF). These findings form the basis of a final... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

More Steps Per Day May Cut Risk for Incident Diabetes in Seniors
THURSDAY, Jan. 27, 2022 -- More steps per day are associated with a reduced risk for incident diabetes in older adults, with a stronger association seen for moderate- to vigorous-intensity (MV-intensity) steps, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

Omicron Linked to Increase in COVID-19 Cases, Lower Disease Severity
THURSDAY, Jan. 27, 2022 -- COVID-19 cases have increased with the emergence of the omicron variant, but disease severity seems not to have increased, according to research published in the Jan. 25 early-release issue of the U.S. Centers for Disease... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

COVID-19 Vaccination Not Linked to Fecundability in Men, Women
THURSDAY, Jan. 27, 2022 -- COVID-19 vaccination is not associated with fecundability among couples trying to conceive, according to a study published online Jan. 20 in the American Journal of Epidemiology. Amelia K. Wesselink, M.P.H., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

Among Young Adults, More Women Than Men Have Ischemic Strokes
THURSDAY, Jan. 27, 2022 -- For young adults (aged 35 years or younger), the incidence of ischemic stroke is higher among women than men, according to a review published in the February issue of Stroke. Michelle H. Leppert, M.D., from the University... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

Cumulative Exposure to Pesticides Linked to Risk for COPD
THURSDAY, Jan. 27, 2022 -- Cumulative exposure to pesticides is associated with an increased risk for chronic obstructive pulmonary disease (COPD), according to a study published online Jan. 26 in Thorax. Sara De Matteis, M.D., M.P.H., Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

Vitamin D Supplementation Linked to Reduction in Autoimmune Disease
THURSDAY, Jan. 27, 2022 -- Vitamin D supplementation, with or without omega-3 fatty acid supplementation, is associated with a significant reduction in the incidence of autoimmune disease, according to a study published online Jan. 26 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

Young Have Greatest Burden of Distant Colorectal Adenocarcinoma
THURSDAY, Jan. 27, 2022 -- The youngest adults have the greatest burden of distant-stage early-onset colorectal adenocarcinoma, according to a study published online Jan. 26 in Cancer Epidemiology, Biomarkers& Prevention. Eric M. Montminy,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

Alterations in Gut Microbiome ID'd in Postacute COVID-19 Syndrome
THURSDAY, Jan. 27, 2022 -- Patients with postacute COVID-19 syndrome (PACS) have alterations in the gut microbiome, according to a study published online Jan. 25 in Gut. Qin Liu, from the Chinese University of Hong Kong, and colleagues conducted a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

Risk for Carditis Tied to Second Dose of Pfizer-BioNTech COVID-19 Vaccine
THURSDAY, Jan. 27, 2022 -- Despite a low absolute risk, there is an increased relative risk for carditis associated with BNT162b2 (Pfizer-BioNTech) vaccination, particularly among men and adolescents, according to a study published online Jan. 25 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news

Atara Biotherapeutics unloads SoCal cell therapy manufacturing facility for $100M
Atara Biotherapeutics Inc. will sell its cell manufacturing center in Thousand Oaks, California, for $100 million to a unit of Japanese conglomerate Fujifilm. The deal for the 90,000-square-foot facility adds enough cash to South San Francisco-based Atara's (NASDAQ: ATRA) coffers to fund operations into late 2023, while Fujifilm Diosynth Biotechnologies, or FDB, lands a beachhead of cell therapy manufacturing. The deal is expected to be completed in Ap ril. FDB plans to offer jobs to about 140… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 27, 2022 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

French care home group Orpea plunged into crisis by mistreatment allegations
Journalist claims systematic negligence in new book based on 3-year investigation (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - January 27, 2022 Category: Pharmaceuticals Source Type: news

SciSparc Presents New Leadership Lineup
TEL AVIV, Israel, Jan. 27, 2022 -- (Healthcare Sales & Marketing Network) -- SciSparc Ltd. (NASDAQ: SPRC) a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the &qu... Biopharmaceuticals, Neurology, Personnel SciSparc Ltd, Tourette syndrome, obstructive sleep apnea, Alzheimer's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 27, 2022 Category: Pharmaceuticals Source Type: news

FX Solutions, SAS. [FX Shoulder, Inc.] Completes Easytech Reversed(R) Stemless IDE Enrollment in the USA
The First-and-Only Completed Stemless Reverse IDE in the USA DALLAS, Jan. 27, 2022 -- (Healthcare Sales & Marketing Network) -- FX has completed the enrollment for their Investigational Device Exemption [IDE] study [G180100] on the Easytech Reversed&re... Devices, Orthopaedic FX Solutions, Easytech Reversed, reverse total shoulder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 27, 2022 Category: Pharmaceuticals Source Type: news

New Funding Fuels Online Therapy Startup Amid Covid-19 Mental Health Crisis
Amidst a brewing mental health crisis, digital therapy startups increase access and reduce strain on the mental health system. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 27, 2022 Category: Pharmaceuticals Authors: Deb Gordon, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Source Type: news

Covid-19 responsible for a third of workplace fatalities in North Carolina
Both 2021 and 2020 saw the number of reported workplace deaths in the state up significantly from the years preceding the pandemic (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 27, 2022 Category: Pharmaceuticals Authors: David Purtell Source Type: news

InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System
InnovHeart and Grand Pharmaceutical Group Enter Into an Exclusive License Agreement to Develop and Commercialize the Saturn TMVR Device in Greater China MILAN, Jan. 27, 2022 -- (Healthcare Sales & Marketing Network) -- InnovHeart s.r.l., a developer of... Devices, Interventional, Cardiology, Venture Capital InnovHeart , Grand Pharma , Transcatheter Mitral Valve Replacement (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 27, 2022 Category: Pharmaceuticals Source Type: news

Biotech gets FDA approval for cell therapy targeting melanoma
The Food and Drug Administration on Wednesday granted marketing approval to Kimmtrak, Immunocore Holdings' cell therapy for metastatic uveal melanoma. Kimmtrak is the first T cell receptor therapeutic to receive regulatory approval by the FDA. It is also the first treatment for the rare and aggressive form of cancer to be approved by the federal agency. Immunocore (NASDAQ: IMCR), a British biotechnology firm based in Oxfordshire, England, has U .S. operations in Conshohocken — where it leases… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 27, 2022 Category: Pharmaceuticals Authors: John George Source Type: news

Johnson & Johnson Marks More Than 2 Billion Doses of Medicine Donated to Date to Help Combat Intestinal Worms
NEW BRUNSWICK, N.J., January 27, 2022 – In advance of World Neglected Tropical Diseases (NTD) Day on January 30, Johnson & Johnson is pleased to announce it has now donated a total of more than 2 billion doses of mebendazole, its medicine to treat intestinal worm infections, to people in need in more than 50 resource-limited countries worldwide. This marks the latest achievement in Johnson & Johnson’s longstanding donation program aimed at helping children, who are especially vulnerable to intestinal worms, live healthier lives. “More than fifteen years ago, Johnson & Johnson committed to addr...
Source: Johnson and Johnson - January 27, 2022 Category: Pharmaceuticals Source Type: news

Triad company buys buildings for $12.15 million
The purchase includes the company's headquarters building. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 27, 2022 Category: Pharmaceuticals Authors: John Brasier Source Type: news

Longtime Raleigh investment firm acquired by Curi subsidiary
Quietly, Raleigh ’s Curi Capital has acquired local investment advisory business KDI Capital Partners. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 27, 2022 Category: Pharmaceuticals Authors: Lauren Ohnesorge Source Type: news

Delta variant, waning immunity reduced Pfizer vaccine's effectiveness against household transmission
A new study by Yale School of Public Health (YSPH) researchers suggests that the Pfizer-BioNTech vaccine was more than 91% effective at reducing transmission of coronavirus in Israeli households before the emergence of the delta variant. However, the combined effect of the new variant and waning vaccine-induced immunity considerably reduced the vaccine's effectiveness against transmission over time. (Source: World Pharma News)
Source: World Pharma News - January 27, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Majority Of Americans Think Covid-19 Is Here To Stay, Poll Finds
Just 15% of Americans polled said they would consider the pandemic over when Covid-19 is largely eliminated, like polio. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 27, 2022 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news

SMi's 9th Annual Conference Pre-Filled Syringes East Coast
25 - 26 April 2022, Boston, MA, USA. The global pre-filled syringes market was valued at $1139.6 million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. With that in mind, the 9th annual Pre-Filled Syringes East Coast conference will bring together leading industry experts representing big pharma and device developers to discuss the key drivers accelerating the expansion of the industry. (Source: World Pharma News)
Source: World Pharma News - January 27, 2022 Category: Pharmaceuticals Tags: Featured Events Source Type: news

GSK kicks off trials of pioneering ‘bioelectronic’ disease treatment
The first patient has been given an implant to control rheumatoid arthritis by modifying nerve signals to the spleen (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - January 27, 2022 Category: Pharmaceuticals Source Type: news

CISCRP Releases Results of the 2021 Perceptions and Insights Study
Captures impact of COVID-19 and evolving participant needs and preferences in clinical research(PRWeb January 27, 2022)Read the full story at https://www.prweb.com/releases/ciscrp_releases_results_of_the_2021_perceptions_and_insights_study/prweb18459095.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 27, 2022 Category: Pharmaceuticals Source Type: news

Sun Pharma launches dry eye treatment product in Canada
The product is the first dry eye treatment available in Canada that is delivered with nanomicellar (NCELL) technology, which improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration, Sun Pharma said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2022 Category: Pharmaceuticals Source Type: news

Pharma industry wants Budget to announce incentives for conducting R & D
"An increase in the budgetary allocation from the current 1.8 per cent of the GDP to 2.5-3 per cent, as envisaged in the National Health Policy 2017 along with a separate allocation for the bio-pharmaceutical sector R&D is imperative," Organisation of Pharmaceutical Producers of India (OPPI) President S Sridhar told PTI. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2022 Category: Pharmaceuticals Source Type: news

JB Chemicals to acquire brands from Sanzyme for Rs 628 crore
JB Chemicals and Pharmaceuticals Ltd on Thursday said it will acquire brands for the Indian market from Sanzyme Pvt Ltd, a player in the probiotics and reproductive health segment, for Rs 628 crore. The brands to be acquired include those in the probiotics portfolio and reproductive health segment of Sanzyme, the company said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2022 Category: Pharmaceuticals Source Type: news

NCPDP Foundation Announces Call for Grant Proposals, Submissions Due...
Areas of Interest: NCPDP’s Specialty Enrollment Standard; RxChange or RxFill in the NCPDP SCRIPT Standard; or Showing How NCPDP Standards Support Value-based Arrangements, Precision Medicine, Social...(PRWeb January 27, 2022)Read the full story at https://www.prweb.com/releases/ncpdp_foundation_announces_call_for_grant_proposals_submissions_due_april_29_2022/prweb18462163.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 27, 2022 Category: Pharmaceuticals Source Type: news

U.S. Office of Science and Technology Senior Advisor to Deliver...
The International Society for Pharmaceutical Engineering (ISPE) announced Matthew Hepburn, MD, Senior Advisor to the Director, Pandemic Prevention, U.S. Office of Science and Technology Policy (OSTP),...(PRWeb January 27, 2022)Read the full story at https://www.prweb.com/releases/u_s_office_of_science_and_technology_senior_advisor_to_deliver_keynote_address_at_the_2022_ispe_facilities_of_the_future_conference/prweb18463825.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 27, 2022 Category: Pharmaceuticals Source Type: news

FDAnews Announces The Drug Industry Daily Newsletter Publication
Get intelligence on key industry issues worldwide to increase one’s competitive edge. Drug Industry Daily is the key to success.(PRWeb January 27, 2022)Read the full story at https://www.prweb.com/releases/fdanews_announces_the_drug_industry_daily_newsletter_publication/prweb18463882.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 27, 2022 Category: Pharmaceuticals Source Type: news

Lupin partners with Exeltis for marketing its specialty drug Solosec in US
ET reported in October about Lupin trying to find a marketing partner or even be open to the idea of possible sale of its key specialty drug Solosec in the US. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2022 Category: Pharmaceuticals Source Type: news

~7 Percent of Lung Transplants Due to COVID-19 Respiratory Failure
WEDNESDAY, Jan. 26, 2022 -- From August 2020 through September 2021, about 7 percent of lung transplantations were performed in patients with COVID-19-related respiratory failure, according to a letter to the editor published online Jan. 26 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 26, 2022 Category: Pharmaceuticals Source Type: news

Booster Shots More Effective During Omicron Emergence Period
WEDNESDAY, Jan. 26, 2022 -- Booster doses seem effective for the severe acute respiratory syndrome coronavirus 2 omicron variant, according to research published in the Jan. 21 early-release issue of the U.S. Centers for Disease Control and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 26, 2022 Category: Pharmaceuticals Source Type: news

Nurse Work Environment Affects Patient Outcome
WEDNESDAY, Jan. 26, 2022 -- Surgical patients in hospitals with good nurse work environments have lower odds of intensive care unit admission and mortality, according to a study published online Dec. 15 in AACN Advanced Critical Care. Anna Krupp,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 26, 2022 Category: Pharmaceuticals Source Type: news